---
schema_version: "secwatch.filing_event.v1"
accession: "0000899923-22-000036"
form_type: "8-K"
ticker: "MYGN"
cik: "0000899923"
company_name: "MYRIAD GENETICS INC"
filed_at: "2022-04-01T23:59:59+00:00"
generated_at: "2026-06-26T11:23:16.707950+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Myriad Genetics settles Vectra test qui tam case for $48M ($45.25M to govt, $2.75M to relator)

## Summary
- Total settlement of $48 million: $45.25M to United States and California, $2.75M to Relator's counsel.
- No admission of liability; company expressly denies allegations in the lawsuit.
- DOJ and State of California declined to intervene after investigation.
- Lawsuit dismissed with prejudice as to Relator and California; federal claims dismissed without prejudice.
- Settlement resolves claims concerning Crescendo's former Vectra test dating back to 2010.

## SEC filing metadata
- accession: 0000899923-22-000036
- form_type: 8-K
- ticker: MYGN
- cik: 0000899923
- company_name: MYRIAD GENETICS INC
- filed_at: 2022-04-01T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/899923/000089992322000036/0000899923-22-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/899923/000089992322000036/mygn-20220401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000899923-22-000036
- JSON: https://secwatch.observer/filing/0000899923-22-000036.json
- Plain text: https://secwatch.observer/filing/0000899923-22-000036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.